PD‐L1 immunohistochemical testing: A review with reference to cytology specimens
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.25043
Abstract: Immunotherapy based on disruption of the PD‐1/PD‐L1 axis is standard of care for many high stage malignancies including melanomas, non‐small cell carcinomas of the lung, triple negative breast carcinomas, and squamous cell carcinomas of the… read more here.
Keywords: immunohistochemical testing; review reference; testing review; cytology specimens ... See more keywords